Morepen Laboratories, 500288, MOREPENLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,827.16
29.12
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,921.40
N/A
6.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.09
11.95
12.04

EBITDA CAGR (%)

10 Years
5 Years
3 Years

28.07
2.17
1.14

PAT CAGR (%)

10 Years
5 Years
3 Years

-
21.28
4.31

P:E (Median)

8 Years
5 Years
3 Years

30.74
32.35
26.07

P:BV (Average)

8 Years
5 Years
3 Years

4.03
4.53
3.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.25
15.00
13.02

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 264.11 189.15 39.63% 290.46 213.49 36.05% 314.60 199.88 57.39% 243.26 189.47 28.39%
Expenses 236.45 172.80 36.83% 260.35 199.71 30.36% 285.27 184.99 54.21% 217.98 170.02 28.21%
EBITDA 27.65 16.35 69.11% 30.11 13.77 118.66% 29.33 14.90 96.85% 25.27 19.45 29.92%
EBIDTM 10.47% 8.64% 10.37% 6.45% 9.32% 7.45% 10.39% 10.26%
Other Income 3.87 1.72 125.00% 2.84 4.60 -38.26% 3.73 2.81 32.74% 1.33 0.28 375.00%
Interest -0.05 0.62 - 1.27 0.54 135.19% 0.29 0.39 -25.64% 0.29 0.42 -30.95%
Depreciation 6.43 7.97 -19.32% 7.05 7.93 -11.10% 7.15 7.63 -6.29% 7.47 10.90 -31.47%
PBT 25.14 9.48 165.19% 24.64 9.90 148.89% 25.62 9.69 164.40% 18.84 8.41 124.02%
Tax 0.00 0.00 0 0.00 0.00 0 0.00 5.15 -100.00% 0.00 0.00 0
PAT 25.14 9.48 165.19% 24.64 9.90 148.89% 25.62 4.54 464.32% 18.84 8.41 124.02%
PATM 9.52% 5.01% 8.48% 4.64% 8.14% 2.27% 7.75% 4.44%
EPS 0.56 0.21 166.67% 0.55 0.22 150.00% 0.57 0.10 470.00% 0.42 0.19 121.05%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 286.60 206.60 38.72% 307.42 230.06 33.63% 336.39 213.43 57.61% 257.64 202.98 26.93%
Expenses 256.20 187.78 36.44% 277.63 214.75 29.28% 304.64 198.37 53.57% 231.07 183.65 25.82%
EBITDA 30.40 18.83 61.44% 29.79 15.30 94.71% 31.75 15.06 110.82% 26.57 19.33 37.45%
EBIDTM 10.61% 9.11% 9.69% 6.65% 9.44% 7.05% 10.31% 9.52%
Other Income 4.16 1.79 132.40% 2.84 4.60 -38.26% 3.73 2.81 32.74% 1.33 0.28 375.00%
Interest -0.05 0.62 - 1.27 0.54 135.19% 0.29 0.39 -25.64% 0.29 0.43 -32.56%
Depreciation 6.98 8.63 -19.12% 7.56 8.54 -11.48% 7.68 8.24 -6.80% 8.06 11.50 -29.91%
PBT 27.64 11.36 143.31% 23.80 10.82 119.96% 27.52 9.24 197.84% 19.55 7.68 154.56%
Tax 0.87 0.34 155.88% 0.01 0.01 0.00% 0.35 5.15 -93.20% 0.19 0.02 850.00%
PAT 26.76 11.02 142.83% 23.79 10.82 119.87% 27.17 4.09 564.30% 19.36 7.66 152.74%
PATM 9.34% 5.33% 7.74% 4.70% 8.08% 1.92% 7.52% 3.77%
EPS 0.59 0.25 136.00% 0.53 0.24 120.83% 0.60 0.09 566.67% 0.43 0.17 152.94%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,112.43 791.99 717.24 560.83 547.51 452.46 370.26 335.97 303.35 269.50 216.31 Net Sales Growth 40.46% 10.42% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% 12.56% 24.59% Cost Of Goods Sold 736.63 487.87 448.98 335.30 328.24 273.04 223.63 194.39 185.79 172.43 140.48 Gross Profit 375.80 304.13 268.26 225.52 219.27 179.42 146.64 141.58 117.56 97.07 75.83 GP Margin 33.78% 38.40% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% 36.02% 35.06% Total Expenditure 1,000.05 727.52 652.22 500.56 487.02 388.26 323.68 290.16 274.37 251.87 209.07 Power & Fuel Cost - 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 % Of Sales - 1.59% 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% 3.64% 3.56% Employee Cost - 98.07 84.74 68.22 60.79 51.67 43.52 39.16 34.47 32.12 26.79 % Of Sales - 12.38% 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% 11.92% 12.39% Manufacturing Exp. - 48.90 31.27 16.21 15.05 13.33 12.63 12.23 11.33 11.34 11.40 % Of Sales - 6.17% 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% 4.21% 5.27% General & Admin Exp. - 31.93 31.21 24.35 21.53 15.34 13.77 14.60 11.43 12.18 10.06 % Of Sales - 4.03% 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% 4.52% 4.65% Selling & Distn. Exp. - 35.75 31.72 29.13 29.04 19.87 16.06 15.11 15.48 10.51 8.27 % Of Sales - 4.51% 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% 3.90% 3.82% Miscellaneous Exp. - 12.45 11.11 16.26 22.53 7.38 6.66 6.25 6.91 3.47 8.27 % Of Sales - 1.57% 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% 1.29% 2.02% EBITDA 112.36 64.47 65.02 60.27 60.49 64.20 46.58 45.81 28.98 17.63 7.24 EBITDA Margin 10.10% 8.14% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% 6.54% 3.35% Other Income 11.77 9.42 3.67 3.54 3.72 1.17 1.36 0.79 2.62 1.02 1.04 Interest 1.80 1.97 2.07 4.29 7.47 10.41 8.63 9.89 11.61 7.96 6.23 Depreciation 28.10 34.43 38.01 33.40 33.56 34.92 38.59 45.77 45.74 46.89 45.78 PBT 94.24 37.48 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 -36.20 -43.73 Tax 0.00 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 0.00 -0.75 Tax Rate 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% 0.00% 1.72% PAT 94.24 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 PAT before Minority Interest 94.24 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.47% 4.08% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% -8.96% -19.87% PAT Growth 191.49% 13.00% 9.53% 12.73% 46.83% 2,620.69% - - - - EPS 2.10 0.72 0.64 0.58 0.52 0.35 0.01 -0.14 -0.50 -0.54 -0.96

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,188.05 853.07 768.54 606.51 595.47 485.08 400.64 366.85 325.92 289.34 228.30 Net Sales Growth 39.27% 11.00% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% 12.64% 26.74% Cost Of Goods Sold 780.54 524.19 479.12 361.28 358.35 293.33 238.62 209.04 193.53 178.07 142.68 Gross Profit 407.51 328.87 289.42 245.23 237.12 191.76 162.02 157.81 132.39 111.27 85.62 GP Margin 34.30% 38.55% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% 38.46% 37.50% Total Expenditure 1,069.54 784.55 701.02 541.78 534.09 423.52 352.41 317.95 294.97 270.11 222.53 Power & Fuel Cost - 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 % Of Sales - 1.47% 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% 3.39% 3.37% Employee Cost - 109.91 95.36 76.53 69.69 58.29 48.79 45.08 39.17 36.05 30.52 % Of Sales - 12.88% 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% 12.46% 13.37% Manufacturing Exp. - 48.92 31.28 16.21 22.36 13.33 12.68 12.23 11.33 10.20 11.40 % Of Sales - 5.73% 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% 3.53% 4.99% General & Admin Exp. - 36.47 36.14 28.52 18.11 18.14 15.89 16.62 13.86 14.37 12.72 % Of Sales - 4.28% 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% 4.97% 5.57% Selling & Distn. Exp. - 40.11 32.73 30.04 25.79 23.45 21.40 19.55 20.40 15.85 11.26 % Of Sales - 4.70% 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% 5.48% 4.93% Miscellaneous Exp. - 12.39 13.20 18.11 29.95 9.35 7.61 7.01 7.72 5.75 11.26 % Of Sales - 1.45% 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% 1.99% 2.74% EBITDA 118.51 68.52 67.52 64.73 61.38 61.56 48.23 48.90 30.95 19.23 5.77 EBITDA Margin 9.98% 8.03% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% 6.65% 2.53% Other Income 12.06 9.48 3.67 3.72 3.72 1.20 1.37 1.22 2.87 1.18 1.04 Interest 1.80 1.98 2.11 4.36 7.56 10.50 8.66 9.92 11.63 7.96 6.27 Depreciation 30.28 36.91 39.90 34.32 33.90 35.20 38.67 45.84 45.80 48.06 48.16 PBT 98.51 39.11 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 -35.61 -47.62 Tax 1.42 5.53 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 0.06 -0.69 Tax Rate 1.44% 14.14% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% -0.25% 1.45% PAT 97.08 33.58 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 -23.65 -46.93 PAT before Minority Interest 97.07 33.58 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 -23.63 -46.93 Minority Interest -0.01 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 -0.02 0.00 PAT Margin 8.17% 3.94% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% -8.17% -20.56% PAT Growth 189.01% 16.40% -2.50% 25.22% 84.61% 498.13% - - - - EPS 2.16 0.75 0.64 0.66 0.53 0.28 0.05 -0.06 -0.46 -0.53 -1.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 307.25 277.46 250.56 224.34 328.85 313.08 324.26 330.42 353.09 377.26 Share Capital 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 217.29 187.50 160.60 134.38 119.24 103.47 114.65 120.81 143.48 167.65 Non-Current Liabilities 25.36 21.11 17.87 15.28 55.22 72.69 84.05 103.36 121.93 134.86 Secured Loans 0.92 1.79 2.70 0.94 42.74 62.22 74.65 94.49 98.85 114.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 Long Term Provisions 22.38 17.85 13.45 12.69 10.71 8.71 7.35 6.78 5.60 3.75 Current Liabilities 329.38 320.82 322.21 308.19 150.78 114.44 99.58 107.72 107.69 103.74 Trade Payables 158.38 157.08 164.89 116.20 107.48 78.55 66.75 54.90 63.59 57.32 Other Current Liabilities 157.39 153.61 156.05 190.70 39.14 32.82 30.91 52.14 43.20 44.68 Short Term Borrowings 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 Short Term Provisions 2.25 1.14 1.26 1.29 4.16 0.84 0.73 0.68 0.90 1.74 Total Liabilities 661.99 619.39 590.64 547.81 534.85 500.21 507.89 541.50 582.71 615.86 Net Block 134.84 152.59 182.10 191.29 216.36 243.93 289.47 330.91 373.57 416.58 Gross Block 641.54 777.14 890.30 922.26 914.18 907.16 902.43 898.34 895.47 896.07 Accumulated Depreciation 506.70 624.55 708.20 730.96 697.82 663.23 612.96 567.43 521.90 479.49 Non Current Assets 313.73 336.06 363.54 369.25 387.98 395.80 415.92 454.30 496.93 539.79 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 118.78 117.69 117.69 117.69 117.69 117.94 117.94 121.81 121.81 121.91 Long Term Loans & Adv. 59.83 65.49 63.47 59.41 53.92 33.93 8.51 1.58 1.55 1.30 Other Non Current Assets 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 348.26 283.33 227.11 178.56 146.88 104.41 91.97 87.20 85.78 76.07 Current Investments 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 132.47 90.84 73.94 62.50 40.82 35.36 32.91 36.75 38.01 33.61 Sundry Debtors 121.41 121.96 110.22 83.10 80.35 48.45 40.09 36.59 33.13 27.73 Cash & Bank 38.03 31.98 5.70 6.75 3.63 8.60 8.07 4.72 3.96 2.34 Other Current Assets 56.35 7.72 5.49 4.55 22.08 12.00 10.90 9.14 10.68 12.39 Short Term Loans & Adv. 50.45 30.80 31.53 21.67 16.27 8.89 7.94 6.56 9.00 9.61 Net Current Assets 18.88 -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 -20.52 -21.91 -27.67 Total Assets 661.99 619.39 590.65 547.81 534.86 500.21 507.89 541.50 582.71 615.86

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 284.06 253.09 225.94 196.26 300.28 287.48 297.11 299.88 320.40 344.05 Share Capital 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 194.10 163.13 135.98 106.30 90.67 77.87 87.50 90.27 110.79 134.44 Non-Current Liabilities 28.42 23.38 20.20 17.80 57.47 74.00 84.65 103.91 122.05 135.01 Secured Loans 0.92 1.83 2.95 1.38 43.41 62.27 74.78 94.65 98.85 114.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 Long Term Provisions 23.82 19.01 14.42 13.59 11.34 9.22 7.82 7.17 5.73 3.90 Current Liabilities 351.44 339.17 340.12 324.86 166.56 127.92 108.14 102.73 104.95 102.78 Trade Payables 172.30 168.15 174.88 124.88 115.33 84.96 68.60 56.81 64.98 59.79 Other Current Liabilities 165.06 160.64 163.90 198.65 47.04 39.87 37.58 45.22 38.96 41.11 Short Term Borrowings 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 Short Term Provisions 2.72 1.39 1.33 1.33 4.19 0.86 0.77 0.70 1.01 1.88 Total Liabilities 663.46 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 Net Block 216.37 236.21 264.29 271.80 296.72 322.48 368.08 409.46 451.86 496.02 Gross Block 752.55 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 997.38 997.96 Accumulated Depreciation 536.18 651.55 733.31 755.15 721.72 686.87 636.53 590.98 545.52 501.94 Non Current Assets 291.29 315.71 342.37 346.34 366.53 374.42 393.18 415.00 457.37 501.38 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 1.08 0.00 0.00 0.00 0.00 0.00 0.00 3.87 3.87 3.97 Long Term Loans & Adv. 73.55 79.22 77.81 73.69 69.82 51.94 25.10 1.67 1.64 1.39 Other Non Current Assets 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 372.18 299.47 243.44 191.95 157.15 114.58 96.32 91.09 89.61 80.02 Current Investments 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 138.48 94.20 76.89 64.66 42.14 37.11 33.30 37.05 38.66 34.70 Sundry Debtors 137.68 133.75 121.85 92.95 87.94 56.14 42.67 39.11 35.15 29.64 Cash & Bank 38.88 32.21 5.95 7.59 4.36 8.85 9.11 5.53 4.51 2.58 Other Current Assets 57.14 7.86 5.62 4.71 22.71 12.48 11.24 9.40 11.29 13.10 Short Term Loans & Adv. 51.16 31.43 32.92 22.03 16.77 9.34 8.23 6.23 9.60 10.30 Net Current Assets 20.73 -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 -11.64 -15.34 -22.76 Total Assets 663.47 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 10.86 14.58 61.25 49.24 50.01 50.74 33.19 33.46 26.77 9.67 PBT 37.48 28.61 26.12 22.55 20.04 0.72 -9.06 -25.75 -36.20 -43.73 Adjustment 34.23 38.36 37.86 40.92 45.32 47.22 55.66 56.73 54.84 52.00 Changes in Working Capital -55.33 -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 -3.91 0.65 Cash after chg. in Working capital 16.38 14.58 61.25 49.24 54.27 50.88 30.29 30.38 14.73 8.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.52 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 0.00 0.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 12.04 0.00 Cash From Investing Activity -12.08 -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 -3.34 -3.85 Net Fixed Assets 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 Net Investments -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 Others -146.61 -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 -4.04 -1.44 Cash from Financing Activity 4.65 -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 -21.81 -4.30 Net Cash Inflow / Outflow 3.43 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 1.62 1.52 Opening Cash & Equivalents 9.36 5.47 6.16 2.87 8.60 8.07 4.72 3.96 2.34 0.82 Closing Cash & Equivalent 12.79 9.36 5.47 6.16 3.63 8.60 8.07 4.72 3.96 2.34

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 11.02 17.37 63.41 40.73 50.07 50.70 33.52 33.64 27.11 11.13 PBT 39.11 29.18 29.77 23.04 17.06 2.28 -5.64 -23.60 -35.61 -47.62 Adjustment 36.63 40.32 38.64 41.40 45.69 47.32 55.76 56.80 55.99 54.44 Changes in Working Capital -58.84 -51.78 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 -5.25 3.63 Cash after chg. in Working capital 16.89 17.71 63.41 40.73 54.34 50.83 30.62 30.56 15.13 10.45 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.88 -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 -0.06 0.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.46 -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 -3.35 -4.05 Net Fixed Assets 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 Net Investments -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 Others -146.99 -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 -4.05 -1.64 Cash from Financing Activity 5.49 -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 -21.83 -5.60 Net Cash Inflow / Outflow 4.04 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 1.93 1.48 Opening Cash & Equivalents 9.60 5.72 7.00 3.60 8.85 9.11 5.53 4.51 2.58 1.10 Closing Cash & Equivalent 13.64 9.60 5.72 7.00 4.36 8.85 9.11 5.53 4.51 2.58

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 6.83 6.17 5.57 4.99 4.65 4.30 4.55 4.69 5.19 5.73 ROA 5.05% 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% -4.03% -6.81% ROE 11.06% 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% -9.84% -15.44% ROCE 9.29% 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% -2.42% -3.29% -7.02% Fixed Asset Turnover 1.12 0.86 0.62 0.60 0.51 0.42 0.38 0.34 0.31 0.25 Receivable days 56.08 59.08 62.91 54.48 50.93 42.76 41.07 41.14 40.65 40.17 Inventory Days 51.46 41.93 44.40 34.44 30.13 32.97 37.31 44.11 47.84 53.30 Payable days 79.07 88.97 104.24 84.35 83.75 77.64 70.84 71.22 76.97 97.16 Cash Conversion Cycle 28.47 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 11.52 -3.69 Total Debt/Equity 0.43 0.47 0.53 0.22 0.20 0.26 0.27 0.34 0.34 0.35 Interest Cover 20.05 14.82 7.08 4.10 2.50 1.08 0.38 -0.95 -2.04 -6.02

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 6.32 5.63 5.02 4.36 4.02 3.73 3.95 4.01 4.46 4.99 ROA 5.25% 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% -4.19% -7.84% ROE 12.50% 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% -11.12% -18.99% ROCE 10.25% 10.01% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% -3.40% -8.22% Fixed Asset Turnover 1.04 0.82 0.60 0.58 0.49 0.41 0.37 0.33 0.29 0.23 Receivable days 58.07 60.70 64.63 55.44 53.22 44.17 40.16 40.83 40.35 42.17 Inventory Days 49.78 40.63 42.59 32.73 29.27 31.48 34.55 41.63 45.68 52.36 Payable days 79.06 88.85 103.38 82.97 83.88 76.01 67.69 69.30 75.59 101.91 Cash Conversion Cycle 28.78 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 10.44 -7.39 Total Debt/Equity 0.47 0.52 0.06 0.25 0.22 0.28 0.30 0.37 0.38 0.39 Interest Cover 20.71 14.83 7.83 4.13 2.21 1.26 0.72 -0.77 -1.96 -6.59

Top Investors:

pinfold overseas limited

ferry holdings limited

damodar prasad agarwal

morepen laboratories limited

Annual Reports:

News Update:

Morepen Laboratories approves Rs 433 crore incoming investment from Corinth and promoters
21st May 2021, 09:15 AM

The meeting of the shareholders of the company was held on May 20, 2021 through video conferencing and other audio-visual means
Read More
Morepen Laboratories gets nod to raise over Rs 433 crore
28th Apr 2021, 12:46 PM

The board of directors of the company considered and approved issue and allotment of up to 10.85 crore equity shares on a preferential basis
Read More
SAT sets aside Sebi's order in Morepen Laboratories case
27th Apr 2021, 12:58 PM

Sebi, in September 2019, had prohibited Morepen Laboratories from the capital market for one year
Read More

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 500288 | NSE: MOREPENLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 500288 | NSE: MOREPENLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: